QuidelOrtho Posts $0.78 Per-Share Loss in Third Quarter
QDEL sits 42% above its 52-week low of $9.92 on elevated volume (1.9× avg).
Summary
QuidelOrtho reported a third-quarter loss of $53.8M, or $0.78 per share, on revenue of $618.9M, per Dow Jones Newswires. That follows a rough second quarter in which revenue came in at $631 million and management cut full-year 2026 revenue, EBITDA and EPS guidance across the board. The Q2 10-Q also showed operating cash flow turning negative while debt rose, and in September the company amended its credit agreement to loosen financial covenants through 2029 — relief, but a sign of balance-sheet strain. The company is launching a restructuring program that eliminates the COO role and expects $80M+ in annual savings from it. A quarterly loss of this size at a company with a sub-$1 billion market cap keeps the pressure on the turnaround story, and third-quarter revenue came in below the $631 million Q2 base.
At the time of this announcement, QDEL was trading at $14.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $966.2M. The 52-week trading range was $9.92 to $35.58. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.